[go: up one dir, main page]

BR9609317A - Preparado de combinação faramacéutica kit e método para a contracepção hormonal - Google Patents

Preparado de combinação faramacéutica kit e método para a contracepção hormonal

Info

Publication number
BR9609317A
BR9609317A BR9609317A BR9609317A BR9609317A BR 9609317 A BR9609317 A BR 9609317A BR 9609317 A BR9609317 A BR 9609317A BR 9609317 A BR9609317 A BR 9609317A BR 9609317 A BR9609317 A BR 9609317A
Authority
BR
Brazil
Prior art keywords
preparation
stage
daily
oestrogen
unit doses
Prior art date
Application number
BR9609317A
Other languages
English (en)
Inventor
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9609317A publication Critical patent/BR9609317A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Surgical Instruments (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR9609317A 1995-06-28 1996-06-27 Preparado de combinação faramacéutica kit e método para a contracepção hormonal BR9609317A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19525017A DE19525017A1 (de) 1995-06-28 1995-06-28 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
PCT/DE1996/001192 WO1997001342A1 (de) 1995-06-28 1996-06-27 Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption

Publications (1)

Publication Number Publication Date
BR9609317A true BR9609317A (pt) 1999-07-06

Family

ID=7766408

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609317A BR9609317A (pt) 1995-06-28 1996-06-27 Preparado de combinação faramacéutica kit e método para a contracepção hormonal

Country Status (22)

Country Link
US (2) US6027749A (pt)
EP (1) EP0835114B1 (pt)
JP (1) JPH11508538A (pt)
CN (1) CN1137690C (pt)
AT (1) ATE239483T1 (pt)
AU (1) AU6352896A (pt)
BR (1) BR9609317A (pt)
CA (1) CA2225724C (pt)
CZ (1) CZ420597A3 (pt)
DE (2) DE19525017A1 (pt)
DK (1) DK0835114T3 (pt)
ES (1) ES2199293T3 (pt)
HU (1) HU223976B1 (pt)
IL (1) IL122109A (pt)
MX (1) MX9800026A (pt)
NO (1) NO317671B1 (pt)
NZ (1) NZ312081A (pt)
PT (1) PT835114E (pt)
RU (1) RU98101254A (pt)
SK (1) SK178097A3 (pt)
WO (1) WO1997001342A1 (pt)
ZA (1) ZA965547B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
HUP9904344A3 (en) * 1996-07-26 2001-03-28 Wyeth Corp Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001015701A1 (en) * 1999-08-31 2001-03-08 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
CA2655959C (en) 2001-12-05 2013-05-14 Robert G. Bell Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
PT1635843E (pt) * 2003-06-25 2009-04-07 Bayer Schering Pharma Ag Terapia de substituição hormonal e de depressão compreendendo dienogest
WO2005007112A2 (en) 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP1673094A1 (en) * 2003-10-01 2006-06-28 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102004026670A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
US20070072836A1 (en) * 2005-02-15 2007-03-29 Sabine Fricke Solid peroral contraceptive preparations
US20060205701A1 (en) * 2005-02-15 2006-09-14 Sabine Fricke Solid peroral contraceptive preparations
PL1848406T3 (pl) * 2005-02-15 2009-06-30 Jenapharm Gmbh Stała, doustna postać leku do antykoncepcji
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1993531B1 (en) * 2006-03-02 2015-10-14 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
CA2740005C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
WO2010042607A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc Transdermal delivery
CA2740004A1 (en) * 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (en) 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
KR102217942B1 (ko) * 2015-06-23 2021-02-19 라보라토리오스 레온 파르마 에스에이 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5320850A (en) 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
ZA965547B (en) 1997-01-27
ES2199293T3 (es) 2004-02-16
DE59610425D1 (de) 2003-06-12
EP0835114B1 (de) 2003-05-07
RU98101254A (ru) 2000-01-27
NO317671B1 (no) 2004-11-29
IL122109A (en) 2006-07-05
WO1997001342A1 (de) 1997-01-16
PT835114E (pt) 2003-09-30
NO976067D0 (no) 1997-12-23
SK178097A3 (en) 1998-05-06
HU223976B1 (hu) 2005-03-29
ATE239483T1 (de) 2003-05-15
HUP9900252A2 (hu) 1999-05-28
NO976067L (no) 1998-02-27
HUP9900252A3 (en) 2001-09-28
JPH11508538A (ja) 1999-07-27
CN1137690C (zh) 2004-02-11
US6312722B1 (en) 2001-11-06
CA2225724A1 (en) 1997-01-16
CN1189101A (zh) 1998-07-29
CA2225724C (en) 2008-01-15
DK0835114T3 (da) 2003-09-01
AU6352896A (en) 1997-01-30
DE19525017A1 (de) 1997-01-02
NZ312081A (en) 1999-04-29
CZ420597A3 (cs) 1998-03-18
MX9800026A (es) 1998-03-31
US6027749A (en) 2000-02-22
EP0835114A1 (de) 1998-04-15
IL122109A0 (en) 1998-04-05

Similar Documents

Publication Publication Date Title
BR9609317A (pt) Preparado de combinação faramacéutica kit e método para a contracepção hormonal
AU2073595A (en) Combined hormonal contraception pharmaceutical preparation
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
NO974630D0 (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
US5516769A (en) Method of inhibiting fertilization
WO1999051214A2 (en) Progestogen-only contraceptive kit

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]